The Hyderabad-based drug maker said in a press release that this will be a multi-center and randomised controlled study, which will include safety and immunogenicity study.from Top Business News- News18.com https://ift.tt/2T1340C
Dr Reddy's Gets DCGI Nod to Conduct Human Trials for Russia's Sputnik V Coronavirus Vaccine
The Hyderabad-based drug maker said in a press release that this will be a multi-center and randomised controlled study, which will include safety and immunogenicity study.from Top Business News- News18.com https://ift.tt/2T1340C
Related Posts
Oil Dips After Surprise Rise In U.S. Crude Stocks; Focus On Biden, Stimulus
Gold Scales Two-week High As Dollar Slips On Stimulus Optimism
Sensex, Nifty Today LIVE Updates: Market at Record High, Sensex Hits 50,000-mark on Global Cues; Reliance, Bajaj Auto Top Gainers
Piramal to Delist DHFL, Shareholders to be Wiped Out
Gold Price Today: Check Rates in Delhi, Kolkata, Chennai and Mumbai
0 comments: